A clinical-stage biotechnology company is expanding its footprint in the United States and Singapore.
Allay Therapeutics announced Jan. 6 it has established its corporate headquarters in San Jose, California, and doubled its research and development operations in Singapore, according to a news release.
"We're pleased to establish a permanent presence in the talent-rich Bay Area and to expand the global facilities supporting the burgeoning pipeline led by our Singapore based team members," Adam Gridley, Allay Therapeutics CEO said. "The new headquarters is designed to enable full integration of our research, manufacturing and pipeline development activities across our global teams, and is a testament to our significant growth as a company over the last year."
Founded in 2017, Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation, the release stated.
"We're grateful for the continued support of our investor group and our medical advisors, and believe we are well positioned to advance revolutionary pain management products from our pipeline supported by a growing world-class team with cutting-edge facilities and technology," Gridley said.
The new San Jose headquarters is in BioSquare, a Silicon Valley life sciences park in North San Jose. The 50,000 square-foot workspace houses Allay Therapeutics' administrative department, as well as its research and development and clinical operations, the release stated. The workspace will also accommodate the company's growing workforce which doubled in the past year.